1. Home
  2. MEOH vs IDYA Comparison

MEOH vs IDYA Comparison

Compare MEOH & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Methanex Corporation

MEOH

Methanex Corporation

N/A

Current Price

$52.66

Market Cap

3.8B

Sector

Industrials

ML Signal

N/A

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

N/A

Current Price

$34.74

Market Cap

2.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MEOH
IDYA
Founded
1968
2015
Country
Canada
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
2.9B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
MEOH
IDYA
Price
$52.66
$34.74
Analyst Decision
Buy
Strong Buy
Analyst Count
8
16
Target Price
$47.75
$51.21
AVG Volume (30 Days)
757.5K
783.9K
Earning Date
01-01-0001
05-19-2026
Dividend Yield
1.47%
N/A
EPS Growth
N/A
61.90
EPS
N/A
N/A
Revenue
N/A
$218,710,000.00
Revenue This Year
$19.36
N/A
Revenue Next Year
$1.17
$213.03
P/E Ratio
$16.44
N/A
Revenue Growth
N/A
3024.43
52 Week Low
$25.46
$13.45
52 Week High
$57.93
$39.28

Technical Indicators

Market Signals
Indicator
MEOH
IDYA
Relative Strength Index (RSI) 55.39 55.27
Support Level $46.36 $32.85
Resistance Level N/A $36.38
Average True Range (ATR) 2.61 1.27
MACD 0.01 0.35
Stochastic Oscillator 47.76 71.26

Price Performance

Historical Comparison
MEOH
IDYA

About MEOH Methanex Corporation

Methanex Corp manufactures and sells methanol. Its customers use methanol as a feedstock to produce end-products including adhesives, foams, solvents, and windshield washer fluids. The firm also sells its products to the oil refining industry, where the methanol is blended with gasoline to produce a high-octane fuel or blended as a component of biodiesel. It distributes its products through an extensive supply chain that includes the operation of port terminals, tankers, barges, rail cars, trucks, and pipelines. The company generates the majority of its revenue from Europe.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: